MUFG Securities EMEA’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-406,000
| Closed | -$74.6M | – | 353 |
|
|
2021
Q2 | $74.6M | Buy |
406,000
+148,000
| +57% | +$27.2M | 0.71% | 17 |
|
|
2021
Q1 | $39.5M | Buy |
+258,000
| New | +$39.5M | 0.32% | 63 |
|
|
2020
Q2 | – | Sell |
-112,000
| Closed | -$10.1M | – | 520 |
|
|
2020
Q1 | $10.1M | Buy |
112,000
+66,000
| +143% | +$5.93M | 0.1% | 143 |
|
|
2019
Q4 | $4.98M | Buy |
46,000
+38,400
| +505% | +$4.15M | 0.04% | 273 |
|
|
2019
Q3 | $744K | Sell |
7,600
-67,400
| -90% | -$6.6M | 0.01% | 275 |
|
|
2019
Q2 | $9.82M | Buy |
+75,000
| New | +$9.82M | 0.1% | 127 |
|
|
2018
Q4 | – | Sell |
-6,042
| Closed | -$840K | – | 727 |
|
|
2018
Q3 | $840K | Buy |
6,042
+5,793
| +2,327% | +$805K | 0.01% | 341 |
|
|
2018
Q2 | $31K | Buy |
+249
| New | +$31K | ﹤0.01% | 326 |
|